☰

Jasmine C. Wong, Ph.D. - Publications

Affiliations: 
2004 University of Toronto, Toronto, ON, Canada 
Area:
Genetics
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater. American Journal of Surgery. PMID 32622509 DOI: 10.1016/J.Amjsurg.2020.05.038  0.305
2020 Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, Jakub JW. Germline Genetic Mutations in a Multi-center Contemporary Cohort of 550 Phyllodes Tumors: An Opportunity for Expanded Multi-gene Panel Testing. Annals of Surgical Oncology. PMID 32504368 DOI: 10.1245/S10434-020-08480-Z  0.313
2020 Zambetti NA, Firestone AJ, Remsberg JR, Huang BJ, Wong JC, Long AM, Predovic M, Suciu RM, Inguva A, Kogan SC, Haigis KM, Cravatt BF, Shannon K. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice. Blood. PMID 32219446 DOI: 10.1182/Blood.2019003530  0.348
2020 Zambetti NA, Firestone AJ, Wong JC, Long AM, Inguva A, Remsberg JR, Suciu RM, Cravatt BF, Haigis KM, Shannon K. Abstract A25: In vivo evidence validating the palmitoylation/depalmitoylation cycle as a therapeutic target in NRAS mutant hematologic cancers Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Ras18-A25  0.346
2020 Wei JM, Kim P, Ewing C, Wong J, Esserman LJ, Alvarado MD, Olusanya AO, Stewart S, Tydon A, Daroui P, Kuo JV, Park HL, Lane KT, Jeong E, Brown K, et al. Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot3-09-01  0.32
2019 Huang BJ, Wandler AM, Meyer LK, Dail M, Daemen A, Sampath D, Li Q, Wang X, Wong JC, Nakitandwe J, Downing JR, Zhang J, Taylor BS, Shannon K. Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias. Plos Genetics. 15: e1008168. PMID 31199785 DOI: 10.1371/Journal.Pgen.1008168  0.399
2018 Wong JC, Bryant V, Lamprecht T, Ma J, Walsh M, Schwartz J, Del Pilar Alzamora M, Mullighan CG, Loh ML, Ribeiro R, Downing JR, Carroll WL, Davis J, Gold S, Rogers PC, et al. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. Jci Insight. 3. PMID 30046003 DOI: 10.1172/Jci.Insight.121086  0.34
2018 Varghese F, Wong J. Breast Cancer in the Elderly. The Surgical Clinics of North America. 98: 819-833. PMID 30005776 DOI: 10.1016/J.Suc.2018.04.002  0.319
2018 Bryant V, Wong J, Schwartz J, Lamprecht T, Ma J, Mullighan C, Loh M, Shannon K, Klco J. Abstract 2063: SAMD9/SAMD9L mutations in familial monosomy 7 Cancer Research. 78: 2063-2063. DOI: 10.1158/1538-7445.Am2018-2063  0.329
2016 Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment. PMID 27785654 DOI: 10.1007/S10549-016-4036-0  0.31
2016 Wandler AM, Huang B, Scacchetti A, Craig J, Yan H, Monsalve G, Li Q, Dail M, Wong JC, Nakitandwe J, Weinberg O, Hasserjian RP, Kogan SC, Sampath D, Downing JR, et al. Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression Blood. 128: 753-753. DOI: 10.1182/Blood.V128.22.753.753  0.315
2015 Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World Journal of Clinical Cases. 3: 607-13. PMID 26244152 DOI: 10.12998/Wjcc.V3.I7.607  0.3
2015 Wong JC, Weinfurtner KM, Alzamora MD, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen SC, Ho TT, Flach J, Reynaud D, Passegué E, Downing JR, et al. Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife. 4. PMID 26193121 DOI: 10.7554/Elife.07839  0.367
2014 Wong JC, Weinfurtner K, Alzamora P, Kogan SC, Burgess MR, Zhang Y, Nakitandwe J, Ma J, Cheng J, Chen S, Flach J, Reynaud D, Passegue E, Downing JR, Shannon K. Aberrant Hematopoietic Stem Cell Function in Mice Haploinsufficient for a 2 Mb Deletion of Chromosome 5A3 Syntenic to a Region of Human 7q22 Frequently Deleted in Myelodysplastic Syndromes Blood. 124: 3247-3247. DOI: 10.1182/Blood.V124.21.3247.3247  0.388
2011 Wong JC, Weinfurtner K, Zhang Y, Alzamora P, Hwang E, Kogan SC, Shannon KM. Heterozygous Germ Line Deletion of a 2Mb Interval in Mice That Models Loss of 7q22 in Human Myeloid Malignancies Results in Defective Hematopoietic Stem Cell Function Reminiscent of Premature Aging Blood. 118: 2340-2340. DOI: 10.1182/Blood.V118.21.2340.2340  0.321
2009 Zhang Y, Wong J, Klinger M, Tran MT, Shannon KM, Killeen N. MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood. 113: 1455-63. PMID 18818388 DOI: 10.1182/Blood-2008-05-159905  0.406
2008 Wong JC, Le Beau MM, Shannon K. Tumor suppressor gene inactivation in myeloid malignancies. Best Practice & Research. Clinical Haematology. 21: 601-14. PMID 19041599 DOI: 10.1016/J.Beha.2008.09.001  0.383
2007 Wong JC, Zhang Y, Tran MT, Lieuw KH, Wolff L, Killeen N, Shannon K. Use of Chromosome Engineering To Model a Leukemia-Associated 7q22 Deletion in the Mouse. Blood. 110: 2654-2654. DOI: 10.1182/Blood.V110.11.2654.2654  0.403
2003 Wong JC, Gokgoz N, Alon N, Andrulis IL, Buchwald M. Cloning and mutation analysis of ZFP276 as a candidate tumor suppressor in breast cancer. Journal of Human Genetics. 48: 668-71. PMID 14605947 DOI: 10.1007/S10038-003-0088-1  0.535
2003 Wong JC, Alon N, Mckerlie C, Huang JR, Meyn MS, Buchwald M. Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Human Molecular Genetics. 12: 2063-76. PMID 12913077 DOI: 10.1093/Hmg/Ddg219  0.55
2002 Wong JC, Buchwald M. Disease model: Fanconi anemia. Trends in Molecular Medicine. 8: 139-42. PMID 11879775 DOI: 10.1016/S1471-4914(01)02262-6  0.537
2000 Wong JC, Alon N, Norga K, Kruyt FA, Youssoufian H, Buchwald M. Cloning and analysis of the mouse Fanconi anemia group A cDNA and an overlapping penta zinc finger cDNA. Genomics. 67: 273-83. PMID 10936049 DOI: 10.1006/Geno.2000.6252  0.522
Show low-probability matches.